{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:05:34Z","timestamp":1775739934315,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bbi.2023.11.018","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:20:59Z","timestamp":1700389259000},"page":"543-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Specific serum autoantibodies predict the development and progression of Alzheimer\u2019s disease with high accuracy"],"prefix":"10.1016","volume":"115","author":[{"given":"Liangjuan","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2023.11.018_b0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jalz.2013.05.1765","article-title":"Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia","volume":"10","author":"Afzal","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2023.11.018_b0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2023.11.018_b0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12974-019-1494-4","article-title":"Antibiotics, gut microbiota, and Alzheimer's disease","volume":"16","author":"Angelucci","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbi.2023.11.018_b0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2023.11.018_b0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-021-00939-9","article-title":"Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231","volume":"13","author":"Bayoumy","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2023.11.018_b0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2023.11.018_b0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000358875","article-title":"Tau-based therapeutic approaches for Alzheimer's disease - a mini-review","volume":"60","author":"Boutajangout","year":"2014","journal-title":"Gerontology"},{"key":"10.1016\/j.bbi.2023.11.018_b0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-018-0284-2","article-title":"Peripheral immune system in aging and Alzheimer's disease","volume":"13","author":"Cao","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2023.11.018_b0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/alz.12447","article-title":"Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease","volume":"18","author":"Chatterjee","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2023.11.018_b0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2023.11.018_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0227-5","article-title":"Tau passive immunization inhibits not only tau but also A\u03b2 pathology","volume":"9","author":"Dai","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2023.11.018_b0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-018-0341-7","article-title":"Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 \u00d7 Tg-AD mice","volume":"10","author":"Dai","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2023.11.018_b0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneuroim.2011.06.013","article-title":"Detection of elevated antibodies against SR protein kinase 1 in the serum of Alzheimer's disease patients","volume":"238","author":"Daniilidou","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2023.11.018_b0070","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3233\/JAD-221091","article-title":"Early detection of Alzheimer's disease-related pathology using a multi-disease diagnostic platform employing autoantibodies as blood-based biomarkers","volume":"92","author":"DeMarshall","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2023.11.018_b0075","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s12035-019-01800-9","article-title":"Candesartan neuroprotection in rat primary neurons negatively correlates with aging and senescence: a transcriptomic analysis","volume":"57","author":"Elkahloun","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2023.11.018_b0080","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1096\/fj.09-139634","article-title":"RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning\/memory in a mouse model of Alzheimer's disease","volume":"24","author":"Fang","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2023.11.018_b0085","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","article-title":"The complexity of Alzheimer's disease: an evolving puzzle","volume":"101","author":"Ferrari","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbi.2023.11.018_b0090","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbi.2023.11.018_b0095","first-page":"7","article-title":"Antibody Therapeutics Targeting A\u03b2 and Tau","author":"Gallardo","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbi.2023.11.018_b0100","unstructured":"GBD 2019 Dementia Forecasting Collaborators. 2022. Estimation of the global prevalence ofdementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.Lancet Public Health 7,e105-e125."},{"key":"10.1016\/j.bbi.2023.11.018_b0105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2023.11.018_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2020.100857","article-title":"Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease","volume":"59","author":"Huang","year":"2020","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.bbi.2023.11.018_b0115","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1212\/WNL.0000000000011226","article-title":"Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease","volume":"96","author":"Ill\u00e1n-Gala","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2023.11.018_b0120","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bbrc.2016.03.152","article-title":"A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain independent manner","volume":"474","author":"Ito","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2023.11.018_b0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2023.11.018_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2014.04.025","article-title":"Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China","volume":"35","author":"Jiao","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2023.11.018_b0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41525-021-00235-3","article-title":"The role of genetics in neurodegenerative dementia: a large cohort study in South China","volume":"6","author":"Jiao","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.bbi.2023.11.018_b0140","doi-asserted-by":"crossref","first-page":"12380","DOI":"10.3390\/ijms140612380","article-title":"Lymphocytes of patients with Alzheimer's disease display different DNA damage repair kinetics and expression profiles of DNA repair and stress response genes","volume":"14","author":"Leandro","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2023.11.018_b0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2022.03.011","article-title":"ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease","volume":"115","author":"Li","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2023.11.018_b0150","first-page":"1959","article-title":"Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbi.2023.11.018_b0155","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2023.11.018_b0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbi.2023.11.018_b0165","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","article-title":"SNMMI procedure standard\/EANM practice guideline for amyloid PET imaging of the brain 1.0","volume":"57","author":"Minoshima","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbi.2023.11.018_b0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2023.11.018_b0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12974-018-1313-3","article-title":"Inflammation: the link between comorbidities, genetics, and Alzheimer's disease","volume":"15","author":"Newcombe","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2023.11.018_b0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13195-018-0371-1","article-title":"Cross-sectional associations of plasma vitamin D with cerebral \u03b2-amyloid in older adults at risk of dementia","volume":"10","author":"Nourhashemi","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbi.2023.11.018_b0185","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2023.11.018_b0190","doi-asserted-by":"crossref","first-page":"e107568","DOI":"10.15252\/embj.2020107568","article-title":"The cellular modifier MOAG-4\/SERF drives amyloid formation through charge complementation","volume":"40","author":"Pras","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.bbi.2023.11.018_b0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2023.11.018_b0200","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2023.11.018_b0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2010.11.054","article-title":"Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening","volume":"144","author":"Reddy","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2023.11.018_b0210","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2023.11.018_b0215","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","article-title":"Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer's disease","volume":"110","author":"Sadick","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2023.11.018_b0220","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1021\/acs.jproteome.9b00258","article-title":"Identification of Alzheimer's Disease Autoantibodies and Their Target Biomarkers by Phage Microarrays","volume":"18","author":"San Segundo-Acosta","year":"2019","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbi.2023.11.018_b0225","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1021\/acs.jproteome.1c00630","article-title":"Multiomics Profiling of Alzheimer's disease serum for the identification of autoantibody biomarkers","volume":"20","author":"San Segundo-Acosta","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbi.2023.11.018_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108104","article-title":"Tau immunotherapies: Lessons learned, current status and future considerations","volume":"175","author":"Sandusky-Beltran","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2023.11.018_b0235","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2023.11.018_b0240","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-141725","article-title":"Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort","volume":"44","author":"Seeburger","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2023.11.018_b0245","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbi.2017.07.158","article-title":"Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model","volume":"66","author":"Son","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.11.018_b0250","doi-asserted-by":"crossref","first-page":"e0033820","DOI":"10.1128\/CMR.00338-20","article-title":"A comprehensive review on the role of the gut microbiome in human neurological disorders","volume":"35","author":"Sorboni","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbi.2023.11.018_b0255","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2023.11.018_b0260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2010.07.020","article-title":"Identification of MOAG-4\/SERF as a regulator of age-related proteotoxicity","volume":"142","author":"van Ham","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2023.11.018_b0265","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/abbs\/gms065","article-title":"Immunotherapy for Alzheimer's disease","volume":"44","author":"Wang","year":"2012","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.bbi.2023.11.018_b0270","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/ene.14290","article-title":"Identification of novel candidate autoantibodies in Alzheimer's disease","volume":"27","author":"Wang","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbi.2023.11.018_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101409","article-title":"The role of the immune system in Alzheimer's disease","volume":"70","author":"Wu","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbi.2023.11.018_b0280","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1093\/brain\/aws271","article-title":"Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias","volume":"135","author":"Yarchoan","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2023.11.018_b0285","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2023.11.018_b0290","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123003513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123003513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:28:36Z","timestamp":1760171316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159123003513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":58,"alternative-id":["S0889159123003513"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2023.11.018","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific serum autoantibodies predict the development and progression of Alzheimer\u2019s disease with high accuracy","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2023.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}